INTS - INTENSITY THERAPEUTICS, INC.
5.3
-0.020 -0.377%
Share volume: 59,820
Last Updated: 04-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$5.32
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 03-13-2025 | 05-13-2025 | 11-06-2025 | 03-27-2026 | |
| Assets | ||||||||
| Total Assets | 12.408 M | 8.673 M | 5.213 M | 4.783 M | 3.065 M | 9.585 M | 14.101 M | |
| Current Assets | 11.169 M | 7.440 M | 3.787 M | 3.363 M | 1.651 M | 8.186 M | 12.709 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 3.039 M | 3.083 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.458 M | 3.241 M | 2.782 M | 2.590 M | 929.000 K | 7.067 M | 11.921 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.239 M | 1.233 M | 1.426 M | 1.420 M | 1.414 M | 1.399 M | 1.392 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 12.408 M | 8.673 M | 5.213 M | 4.783 M | 3.065 M | 9.585 M | 14.101 M | |
| Total liabilities | 2.686 M | 3.328 M | 2.434 M | 1.865 M | 2.731 M | 2.363 M | 2.225 M | |
| Total current liabilities | 2.519 M | 3.204 M | 2.317 M | 1.755 M | 2.629 M | 2.276 M | 2.146 M | |
| Accounts Payable | 1.219 M | 1.919 M | 540.000 K | 1.219 M | 1.586 M | 1.684 M | 583.000 K | |
| Other liabilities | 167.000 K | 124.000 K | 117.000 K | 110.000 K | 102.000 K | 87.000 K | 79.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 167.000 K | 124.000 K | 117.000 K | 110.000 K | 102.000 K | 87.000 K | 79.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.722 M | 5.345 M | 2.779 M | 2.918 M | 334.000 K | 7.222 M | 11.876 M | |
| Common stock | 64.840 M | 65.434 M | 66.381 M | 69.701 M | 70.464 M | 82.560 M | 90.265 M | |
| Retained earnings | -55.118 M | -60.089 M | -63.602 M | -66.783 M | -70.130 M | -75.338 M | -78.389 M |